PYXIS ONCOLOGY INC. - COMMON STOCK

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 7 2022 06:45:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference

28 6 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology Announces Presentations at Upcoming Investor Conferences

19 5 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update

13 5 2022 08:03:06 提供 Nasdaq GlobeNewswire

Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference

27 4 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology Announces Leadership Changes

13 4 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting

08 4 2022 13:05:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate and Financial Update

29 3 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022

22 3 2022 06:35:00 提供 Nasdaq GlobeNewswire

Pyxis to be Added to Russell 2000® Index

15 12 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer

09 12 2021 08:30:00 提供 Nasdaq GlobeNewswire

Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update

15 11 2021 07:15:00 提供 Nasdaq GlobeNewswire

Pyxis Oncology to Present at the Jefferies London Healthcare Conference

10 11 2021 08:00:02 提供 Nasdaq GlobeNewswire

Pyxis Announces Pricing of Upsized Initial Public Offering

07 10 2021 22:24:50 提供 Nasdaq GlobeNewswire